Tuberculosis and HIV Co-infection, California, USA, 1993-2008

被引:19
作者
Metcalfe, John Z. [1 ]
Porco, Travis C. [1 ]
Westenhouse, Janice [2 ]
Damesyn, Mark [3 ]
Facer, Matt [3 ]
Hill, Julia [2 ]
Xia, Qiang [4 ]
Watt, James P. [2 ]
Hopewell, Philip C. [1 ]
Flood, Jennifer [2 ]
机构
[1] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94110 USA
[2] Calif Dept Publ Hlth, Richmond, CA USA
[3] Calif Dept Publ Hlth, Sacramento, CA USA
[4] RTI Int, Res Triangle Pk, NC USA
基金
美国国家卫生研究院;
关键词
SUB-SAHARAN AFRICA; UNITED-STATES; MYCOBACTERIUM-TUBERCULOSIS; ANTIRETROVIRAL THERAPY; INFECTION; COHORT; DEATH; AIDS; EPIDEMIOLOGY; MORTALITY;
D O I
10.3201/eid1903.121521
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To understand the epidemiology of tuberculosis (TB) and HIV co-infection in California, we cross-matched incident TB cases reported to state surveillance systems during 1993-2008 with cases in the state HIV/AIDS registry. Of 57,527 TB case-patients, 3,904 (7%) had known HIV infection. TB rates for persons with HIV declined from 437 to 126 cases/100,000 persons during 1993-2008; rates were highest for Hispanics (225/100,000) and Blacks (148/100,000). Patients co-infected with TB-HIV during 2001-2008 were significantly more likely than those infected before highly active antiretroviral therapy became available to be foreign born, Hispanic, or Asian/Pacific Islander and to have pyrazinamide-monoresistant TB. Death rates decreased after highly active antiretroviral therapy became available but remained twice that for TB patients without HIV infection and higher for women. In California, HIV-associated TB has concentrated among persons from low- and middle-income countries who often acquire HIV infection in the peri-immigration period.
引用
收藏
页码:400 / 406
页数:7
相关论文
共 38 条
[1]   Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993-2004 [J].
Albalak, Rachel ;
O'Brien, Richard J. ;
Kammerer, J. Steve ;
O'Brien, Sean M. ;
Marks, Suzanne M. ;
Castro, Kenneth G. ;
Moore, Marisa .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (22) :2443-2452
[2]  
BACCHETTI P, 1993, STAT SCI, V8, P82, DOI 10.1214/ss/1177010994
[3]   Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study [J].
Badri, M ;
Wilson, D ;
Wood, R .
LANCET, 2002, 359 (9323) :2059-2064
[4]   Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli [J].
Behr, MA ;
Warren, SA ;
Salamon, H ;
Hopewell, PC ;
de Leon, AP ;
Daley, CL ;
Small, PM .
LANCET, 1999, 353 (9151) :444-449
[5]   Causes of Death in HIV-infected Persons Who Have Tuberculosis, Thailand [J].
Cain, Kevin P. ;
Anekthananon, Thanomsak ;
Burapat, Channawong ;
Akksilp, Sornsalk ;
Mankhatitham, Wiroj ;
Srinalk, Chawin ;
Nateniyom, Sriprapa ;
Sattayawuthipong, Wanchai ;
Tasaneeyapan, Theerawit ;
Varma, Jay K. .
EMERGING INFECTIOUS DISEASES, 2009, 15 (02) :258-264
[6]  
Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P361
[7]  
Centers for Disease Control and Prevention, 2012, MMWR-MORBID MORTAL W, V61, P181
[8]  
Centers for Disease Control and Prevention (CDC), 2009, DIAGN HIV INF AIDS U
[9]  
Chamie G, 2010, INT J TUBERC LUNG D, V14, P1295
[10]   Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-Analyses [J].
Chang, Kwok Chiu ;
Yew, Wing Wai ;
Zhang, Ying .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (10) :4499-4505